Crypto· Crypto Regulation

SEC and FDA Announce MOU to Bolster Cooperation and Ensure Market Integrity

Press Release Washington D.C., Aug. 31, 2026 — The Securities and Exchange Commission and the Food and Drug Administration today announced that they have entered into a Memorandum of Understanding (MOU) designed to assist the agencies in carrying out their respective missions of ensuring the integrity of the financial markets and protecting public health.

By AI NewsroomPublished about 24 hours agoUpdated about 1 hour ago1 views

SEC and FDA Announce MOU to Bolster Cooperation and Ensure Market Integrity

Why It Matters

This story touches on sec, mou, fda — topics readers are actively tracking. Review and add editorial context before publishing.

Key Facts

Fact 1: 31, 2026 — The Securities and Exchange Commission and the Food and Drug Administration today announced that they have entered into a Memorandum of Understanding (MOU) designed to assist the agencies in carrying out their respective missions of ensuring the integrity of the financial markets and protecting public health.
Fact 2: 31, 2026

The MOU establishes a framework for the agencies to enhance cooperation in their regulatory and enforcement responsibilities in order to improve market oversight and compliance. Among other things, the MOU includes information-sharing protocols to facilitate the exchange of information between the SEC and FDA that is relevant to both agencies’ important missions. “FDA-related disclosures by public companies have a significant impact on our markets,” said SEC Chairman Paul S.

(Original synthesis pending human/AI review — generated by the stub provider by selecting real sentences from the source material, not by writing new analysis or commentary.)